C
COEP
Coeptis Therapeutics Inc
11.98
+0.70+6.21%After Hours: 11.98 0.00 0.00%16:10 04/02 EDT
OPEN/PREV CLOSE11.09/11.28
TODAY RANGE11.04-11.98
VOL17.41K
MARKET CAP74.55M
52 WEEK RANGE6.26-21.41
AVG VOL (3M)50.73K
% TURNOVER0.28%
TURNOVER--
P/E (TTM)-4.2571
% RANGE8.33%
EPS(TTM)-2.8141
P/E(FORWARD)-3.5235
P/B5.08
BVPS2.360
DIVIDEND--
P/S50.51
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP64.32M
SHARES OUTSTANDING6.22M
NEXT EARNINGS05/14-05/20
FREE FLOAT5.37M
LOT SIZE1
EX-DATE12/31/2024
News
Press Releases
Financial Reports
Profile
Reuters·03/23 21:16
Coeptis acquires NexGenAI Affiliates Network marketing automation platform
TipRanks·02/12 22:34
Coeptis Reprices Equity Awards and Accelerates Option Vesting
Reuters·02/12 22:01
Coeptis Therapeutics Launches One-Time Option Repricing and Exchange Program
Benzinga·02/05 21:02
Coeptis Therapeutics Shareholders Approve Proposed Merger With Z Squared
Reuters·02/05 21:02
Coeptis Shareholders Approve Z Squared Merger
Reuters·02/05 21:00
COEPTIS RECEIVES SHAREHOLDER APPROVAL TOWARDS Z SQUARED MERGER
Dow Jones·02/05 21:00
Press Release: Coeptis Receives Shareholder Approval Towards Z Squared Merger
TipRanks·02/04 22:13
Coeptis Shareholders Approve Merger, Spin-Out and Rebranding
Reuters·02/04 21:31
Coeptis Therapeutics Holdings Inc. held shareholder meeting
TipRanks·01/16 22:03
Coeptis Therapeutics Addresses Nasdaq Listing Compliance Deficiency
TipRanks·01/06 13:35
Coeptis Therapeutics S-4 declared effective by SEC
Reuters·01/06 13:19
Coeptis Therapeutics S-4 for Z Squared Merger Declared Effective by SEC
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.